Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Usability of 4Fluart ID Influenza Vaccine in Adults
NCT03448705Phase 1Completed
- Sponsor
- Fluart Innovative Vaccines
- Start
- Jan 2018
- Primary completion
- Apr 2018
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 1, randomised, single-blind trial of 4FLUART in influenza (3 arms), sponsored by Fluart Innovative Vaccines. Primary endpoint: Safety in terms of safety concerns emerged. Started Jan 2018; status: completed.
02
Drugs
4FLUART
03
Conditions
influenza
Beyond the preview
Go deeper on NCT03448705.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03448705.